CHANGE IN RATINGS

AmerisourceBergen ( ABC) upgraded at Deutsche to Buy. $41.50 price target. Company has the cleanest fundamentals in the business. Expect little industry reform risk.

DryShips ( DRYS) upgraded at Oppenheimer from Perform to Outperform. $8 price target. See little further dilution after the latest offering.

Fidelity National ( FIS) upgraded at Oppenheimer. Rating raised to Outperform from Perform. Establishes price target of $25. Maintains 2009 EPS estimates of $1.61.

Illinois Tool Works ( ITW) downgraded at BB&T from Buy to Hold. Valuation call, as sales are weak but stable.

Palm ( PALM) downgraded at Morgan Joseph from Buy to Hold. Valuation call, with the stock reaching the $10 price target.

Quality Systems ( QSII) downgraded at BB&T to Hold. Valuation call, as the stock is up 79% since December 3.

STOCK COMMENTS / EPS CHANGES

Advanced Micro Devices ( AMD) estimates lowered at UBS. AMD loss estimates widened through 2010. Company seeing higher sales on improved PC trends, but is realizing higher loss from the Globalfoundries subsidiary. Neutral rating and $2.20 price target.

Baxter ( BAX) estimates raised at UBS through 2010. Bioscience division continues to be the main growth driver. Buy rating and $60 price target.

Bed, Bath & Beyond ( BBBY) numbers upped at Barclays to $27. Estimates also increased, following an upbeat meeting with management. Equal-weight rating.

Biogen Idec ( BIIB) estimates, target raised at Barclays to $40. Estimates also raised to reflect lower tax rates. Underweight rating.

Crown Holdings ( CCK) numbers raised at UBS to $29. Estimates also increased, because of improved operating efficiency. Buy rating.

Cypress Semi ( CY) estimates lowered at UBS through 2010. Company realizing better sales, but is facing higher stock compensation costs. Neutral rating and $7 price target.

Cypress Semi ( CY) numbers increased at Barclays to $9. Estimates also raised, to reflect higher sales demand. Overweight rating.

Google ( GOOG) estimates raised at Barclays through 2010, Barclays Capital said. Company is seeing leverage on cost controls. Overweight rating and $460 price target.

Intuitive Surgical ( ISRG) estimates raised at Morgan Stanley through 2010. Company posted a strong quarter, and the buyback program helped to boost earnings. Equal-weight rating.

Nokia ( NOK) estimates, target raised at Barclays through 2010. Company is selling more handsets and visibility is improving. Overweight rating and new $17 price target.

Parker Hannifin ( PH) estimates reduced at UBS through 2010. Demand remains weak, with little visibility for a turnaround. Neutral rating and $39 price target.

Sprint Nextel ( S) estimates upped at Morgan Stanley through 2011. Company is seeing growth in pre-paid subscribers, though contract customers continue to fall. Underweight rating and $1 price target.

Sandisk ( SNDK) estimates raised at UBS; loss estimates improved. Company realizing higher average selling prices. Neutral rating and $11.50 price target.

Textron ( TXT) target raised at Merrill/BofA to $12.50. Stock continues to trade with buyout rumors. Neutral rating.

This article was written by a staff member of TheStreet.com.

More from Stocks

Why The FANG Stocks' Dominance May Not Be So Bad For The Market

Why The FANG Stocks' Dominance May Not Be So Bad For The Market

Danica Patrick's Final Race at 2018 Indianapolis 500: What She Thinks About Cars

Danica Patrick's Final Race at 2018 Indianapolis 500: What She Thinks About Cars

At End of May, Investors Signalling They May Stay Away

At End of May, Investors Signalling They May Stay Away

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Neel Kashkari: The Heart of Our Financial System Is More Radioactive Than Ever

Neel Kashkari: The Heart of Our Financial System Is More Radioactive Than Ever